Skip to main content
PACIFIC EDGE LIMITED logo

PACIFIC EDGE LIMITED — Investor Relations & Filings

Ticker · PEB ISIN · NZPEBE0002S1 LEI · 9845007EDCF068FFEA12 ASX Professional, scientific and technical activities
Open in API
Filings indexed 747 across all filing types
Latest filing 2021-09-22 Annual Report
Country NZ New Zealand
Listing ASX PEB

About PACIFIC EDGE LIMITED

https://www.pacificedgedx.com/

Pacific Edge Limited is a cancer diagnostics company specializing in the development and commercialization of non-invasive molecular diagnostic tests. The company's primary product suite, Cxbladder, utilizes advanced mRNA biomarker technology to detect and monitor bladder cancer from urine samples. These genomic tests are designed to assist clinicians in the evaluation of patients presenting with hematuria and in the ongoing surveillance of patients previously diagnosed with the disease. By providing high sensitivity and negative predictive value, the Cxbladder suite helps to accurately rule out urothelial carcinoma, potentially reducing the requirement for invasive clinical procedures such as cystoscopy. The company focuses on integrating its diagnostic tools into standard clinical pathways to improve patient outcomes and healthcare efficiency.

Recent filings

Filing Released Lang Actions
Consolidated Financial Statements 31 March 2020 42 pages 426.2KB
Annual Report Classification · 100% confidence The document contains detailed consolidated financial statements for the year ended 31 March 2020, including a statement of comprehensive income, statement of changes in equity, balance sheet, statement of cash flows, notes to the financial statements, and an independent auditor's report. The presence of full financial data, notes, and audit report indicates this is a comprehensive annual financial report. The fiscal period is a full year ending 31 March 2020, consistent with an annual report. The document length is substantial (15,000 characters), and it is not merely an announcement or certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2020
2021-09-22 English
ASX market release - Admission & quotation 2 pages 107.3KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from ASX regarding the commencement of official quotation of Pacific Edge Limited as a Foreign Exempt Listing on the ASX. It provides details about the quotation date, securities, and company information but does not contain financial statements, detailed financial performance, or management discussion. The document length is short (2654 characters) and it is clearly an announcement about the listing event rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-09-21 English
ASX market release - Admission & quotation 2 pages 107.3KB
Regulatory Filings Classification · 95% confidence The document is a market announcement regarding the commencement of official quotation of Pacific Edge Limited as an ASX Foreign Exempt Listing. It provides details about the listing date, quotation information, company details, and regulatory disclaimers. There are no financial statements, management discussion, or detailed report content. The document is an announcement about a listing event rather than a financial report or detailed filing. It is not a report publication announcement since it does not mention the release or availability of a report, but rather the start of trading on the exchange. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-09-21 English
D&O Ongoing Disclosure – Grant Gibson
Regulatory Filings
2021-09-17 English
Capital Change Notice
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Pacific Edge Limited Capital Change Notice' and details the issuance of 10,000 ordinary shares at $0.48 per share due to the exercise of options. It includes specifics such as the number of shares issued, price, authority for the issue, and dates. The content focuses exclusively on a capital change event, specifically a share issuance. The document length is 2829 characters, which is relatively short but contains detailed information about the capital change rather than just an announcement of a report. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2021-09-17 English
Capital Change Notice
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Pacific Edge Limited Capital Change Notice' and details the issuance of ordinary shares as a capital change. It includes specifics such as the number of shares issued, price per share, reason for issue (shares in lieu of bonus), and authority for the issue. The document is short (2838 characters) and focuses solely on a capital structure change without financial statements or broader financial performance data. This matches the definition of a 'Share Issue/Capital Change' announcement rather than a full financial report or other filing types.
2021-09-17 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.